Home
Welcome to the German Pavilion!
18-21 May 2009
Atlanta, Georgia, USA
Germany as a dynamic and competitive biotechnology center:
• Top position as regards the number of Core-Biotechnology companies in Europe
• 14,000 employees generate a sales volume worth more than 2 billion €
• 134 drugs on the market
Research and development – a strong German domain:
• Specific research promotion involving more than 1 billion € in 2008 for biotech R&D alone (in core-biotech companies)
• Internationally renowned research institutions such as the Max Planck Society, the Helmholtz Association of National Research Centers, Fraunhofer Gesellschaft
• Establishment of science and innovation clusters as centers for expertise
At BIO 2009 in Atlanta more than 120 German companies and institutions will present themselves with their ambitious product developments and services in the 13th German joint presentation at BIO annual convention. These companies and institutions are convinced that their products and ideas will be received with great interest.
The German Federal Ministry of Economics and Technology (BMWi), the German Federal Ministry of Education and Research (BMBF), the Association of the German Trade Fair Industry (AUMA), the German Association of Biotechnology Industries (DIB) and the Association of German Biotechnology Companies (VBU) welcome you to the official German presentation at BIO 2009 in Boston.
